“immunosuppressant drugs”的搜索结果，显示 101-110 项，共有 4406 项

1. 肺科- 临床试验- 妙佑医疗国际

   The purpose of this study is to determine whether 2-drug therapy is non-inferior to 3-drug therapy against pulmonary mycobacterium avium complex (MAC) disease, ...

2. 妙佑医疗国际移植中心- 临床试验

   Rochester, Minn. The purpose of this study is to attempt to improve outcomes after kidney transplantation and to improve the safety of living kidney donation ...

3. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The median survival of patients with LM with treatment is generally less than 5 months. There are four FDA-approved drugs for intra-CSF use in LM, but all ...

4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Olaparib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy, such as temozolomide, work ...

5. 整合医学与健康- 概述 - 妙佑医疗国际

   AskMayoExpert. Integrative medicine (complementary and alternative medicine). Rochester, Minn.: Mayo Foundation for Medical Education and Research; 2019 ...

6. 内分泌科- 临床试验- 妙佑医疗国际

   Participants will receive semaglutide (active medicine) or placebo ('dummy medicine'). This is known as participants' study medicine - which treatment ...

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Selumetinib is a drug that works by blocking some enzymes that low grade glioma tumor cells need for their growth. This results in killing tumor cells. Drugs ...

8. 内分泌科- 临床试验- 妙佑医疗国际

   Participants will receive semaglutide (active medicine) or placebo ('dummy medicine'). This is known as participants' study medicine - which treatment ...

9. 药物成瘾（物质使用障碍） - 症状与病因- 妙佑医疗国际

   gov/drug-topics/commonly-used-drugs-charts. Accessed Aug. 16, 2022. Drugs, brains, and behavior: The science of addiction. National Institute on Drug Abuse.

10. 肾病和高血压- 临床试验- 妙佑医疗国际

    This is known as participants' study medicine - which treatment participants get is decided by chance. Semaglutide is a medicine, doctors can prescribe in some ...